Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate for ADHD Symptoms in Autism
NCT00178503Phase 3Completed
- Sponsor
- UTHealth Houston
- Start
- Sep 2005
- Primary completion
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of methylphenidate in attention deficit hyperactivity disorder (ADHD), sponsored by UTHealth Houston. Started Sep 2005; status: completed.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00178503.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00178503.